Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets
Advanced Science · 2024-08 · 11 (29)
DOI: 10.1002/advs.202400545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.05.2024. Verfasst von Swagata Ghatak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, 92037, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Induced Pluripotent Stem Cells, Proteomics, Neurons. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NIMH NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Standard single‐cell (sc) proteomics of disease states inferred from multicellular organs or organoids cannot currently be related to single‐cell physiology. Here, a scPatch‐Clamp/Proteomics platform is developed on single neurons generated from hiPSCs bearing an Alzheimer's disease (AD) genetic mutation and compares them to isogenic wild‐type controls. This approach provides both current and voltage electrophysiological data plus detailed proteomics information on single‐cells. With this new method, the authors are able to observe hyperelectrical activity in the AD hiPSC‐neurons, similar to that observed in the human AD brain, and correlate it to ≈1400 proteins detected at the single neuron level. Using linear regression and mediation analyses to explore the relationship between the abundance of individual proteins and the neuron's mutational and electrophysiological status, this approach yields new information on therapeutic targets in excitatory neurons not attainable by traditional methods. This combined patch‐proteomics technique creates a new proteogenetic‐therapeutic strategy to correlate genotypic alterations to physiology with protein expression in single‐cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA.
- Quantitative Medicine and Systems Biology, The Translational Genomics Research Institute, Phoenix, AZ, 85004, USA.
- Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
ORCID-Profile: Stuart A Lipton
Förderung
- NIH HHS
- NIA NIH HHS
- NIMH NIH HHS
- NIEHS NIH HHS
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Ghatak, S., Diedrich, J. K., Talantova, M., Bhadra, N., Scott, H., Sharma, M., Albertolle, M., Schork, N. J., Yates, J. R., & Lipton, S. A. (2024). Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets. Advanced Science, 11(29). https://doi.org/10.1002/advs.202400545
Vancouver
Ghatak S, Diedrich JK, Talantova M, Bhadra N, Scott H, Sharma M, et al. Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets. Advanced Science. 2024;11(29). doi:10.1002/advs.202400545
BibTeX
@article{Ghatak2024,
author = {Ghatak, Swagata and Diedrich, Jolene K and Talantova, Maria and Bhadra, Nivedita and Scott, Henry and Sharma, Meetal and Albertolle, Matthew and Schork, Nicholas J and Yates, John R and Lipton, Stuart A},
title = {Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {29},
doi = {10.1002/advs.202400545}
}
EUVIMED